{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:30:08Z","timestamp":1791891008053,"version":"4.3.4"},"reference-count":196,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1378\/chest.126.3_suppl.401s","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T18:47:46Z","timestamp":1095792466000},"page":"401S-428S","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1011,"special_numbering":"S","title":["Antithrombotic Therapy for Venous Thromboembolic Disease"],"prefix":"10.1016","volume":"126","author":[{"given":"Harry R.","family":"B\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russel D.","family":"Hull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hyers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary E.","family":"Raskob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.3_suppl.401S_bib1","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(60)92299-6","article-title":"Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial","volume":"1","author":"Barrit","year":"1960","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(66)90822-1","article-title":"Heparin therapy in thromboembolic disease","volume":"1","author":"Kernohan","year":"1966","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1001\/jama.1976.03270140029017","article-title":"Mortality in patients treated for pulmonary embolism","volume":"236","author":"Alpert","year":"1976","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib4","first-page":"519","article-title":"Heparin in the treatment of pulmonary thromboembolism","volume":"32","author":"Kanis","year":"1974","journal-title":"Thromb Diath Haemorrh"},{"key":"10.1378\/chest.126.3_suppl.401S_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(86)91431-5","article-title":"Safety and efficacy of warfarin started early after submassive venous thrombosis or pulmonary embolism","volume":"2","author":"Gallus","year":"1986","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib6","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199005033221802","article-title":"Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis","volume":"322","author":"Hull","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-126-2-199701150-00006","article-title":"Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy","volume":"126","author":"Harrison","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archinte.159.1.46","article-title":"A randomized trial comparing 5-mg and 10-mg warfarin loading doses","volume":"159","author":"Crowther","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.7326\/0003-4819-138-9-200305060-00007","article-title":"Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial","volume":"138","author":"Kovacs","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-119-2-199307150-00002","article-title":"Establishing a therapeutic range for heparin therapy","volume":"119","author":"Brill-Edwards","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.1994.00420010073009","article-title":"A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin","volume":"154","author":"Levine","year":"1994","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1992.00400200027006","article-title":"Optimal therapeutic level of heparin therapy in patients with venous thrombosis","volume":"152","author":"Hull","year":"1992","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib13","doi-asserted-by":"crossref","first-page":"874","DOI":"10.7326\/0003-4819-119-9-199311010-00002","article-title":"The weight-based heparin dosing nomogram compared with a \u201cstandard care\u201d nomogram: a randomized controlled trial","volume":"119","author":"Raschke","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.1991.00400020085018","article-title":"A standard heparin nomogram for the management of heparin therapy","volume":"151","author":"Cruickshank","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib15","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1001\/archinte.159.17.2029","article-title":"Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times","volume":"159","author":"Anand","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib16","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199211193272103","article-title":"Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis","volume":"327","author":"Brandjes","year":"1992","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.401S_bib17","doi-asserted-by":"crossref","first-page":"108S","DOI":"10.1378\/chest.119.1_suppl.108S","article-title":"Hemorrhagic complications of anticoagulant treatment","volume":"119","author":"Levine","year":"2001","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM197505152922002","article-title":"Management of heparin therapy: controlled prospective trial","volume":"292","author":"Salzman","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib19","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.1976.03270130027021","article-title":"Randomized prospective trial of continuous vs intermittent heparin therapy","volume":"236","author":"Glazier","year":"1976","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0002-8703(79)90349-1","article-title":"Heparin therapy: a randomized prospective study","volume":"97","author":"Wilson","year":"1979","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib21","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0140-6736(77)92388-1","article-title":"Haemorrhagic complications of heparin therapy","volume":"1","author":"Mant","year":"1977","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.0954-6820.1981.tb09831.x","article-title":"Heparin treatment of deep vein thrombosis: effects and complications after continuous or intermittent heparin administration","volume":"210","author":"Fagher","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1378\/chest.126.3_suppl.401S_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/0002-9343(81)90537-4","article-title":"Heparin therapy in venous thromboembolism","volume":"70","author":"Wilson","year":"1981","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/0003-4819-116-4-279","article-title":"Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: a meta-analysis","volume":"116","author":"Hommes","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.1995.00430060059007","article-title":"Treatment of deep venous thrombosis with low-molecular-weight heparins: a meta-analysis","volume":"155","author":"Lensing","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.160.2.181","article-title":"A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency","volume":"160","author":"Dolovich","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib27","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM199603143341101","article-title":"A Comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis","volume":"334","author":"Levine","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib28","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJM199603143341102","article-title":"Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home: the Tasman Study Group","volume":"334","author":"Koopman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1056\/NEJM199709043371001","article-title":"Low-molecular-weight heparin in the treatment of patients with venous thromboembolism","volume":"337","author":"The Columbus Investigators","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00063198-200109000-00019","article-title":"Outpatient treatment of patients with deep-vein thrombosis or pulmonary embolism","volume":"7","author":"Wells","year":"2001","journal-title":"Curr Opin Pulm Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib31","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/archinte.158.18.2001","article-title":"Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin","volume":"158","author":"Harrison","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/0003-4819-134-3-200102060-00009","article-title":"Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease","volume":"134","author":"Merli","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib33","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0037-1615089","article-title":"Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis","volume":"79","author":"Charbonnier","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0002-9343(90)90148-7","article-title":"Randomized controlled trial of tissue plasminogen activator in proximal deep venous thrombosis","volume":"88","author":"Goldhaber","year":"1990","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib35","series-title":"Vascular diagnosis.","first-page":"875","article-title":"Rationale and results of thrombolytic therapy for deep vein thrombosis","author":"Lensing","year":"1994"},{"key":"10.1378\/chest.126.3_suppl.401S_bib36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1051-0443(07)61420-1","article-title":"Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis","volume":"11","author":"Ouriel","year":"2000","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib37","first-page":"188","article-title":"Surgical treatment of iliofemoral vein thrombosis technical aspects: possible secondary interventions","volume":"8","author":"Winter","year":"1989","journal-title":"Int Angiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib38","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/00000658-196810000-00009","article-title":"Five-year follow-up study of iliofemoral venous thrombectomy","volume":"168","author":"Lansing","year":"1968","journal-title":"Ann Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM199802123380701","article-title":"A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis","volume":"338","author":"Decousus","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib40","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0049-3848(94)90100-7","article-title":"Anticoagulant therapy in deep venous thrombosis: a randomized controlled study","volume":"73","author":"Nielsen","year":"1994","journal-title":"Thromb Res"},{"key":"10.1378\/chest.126.3_suppl.401S_bib41","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1161\/01.CIR.102.22.2726","article-title":"Treatment of proximal deep vein thrombosis with a novel synthetic compound (SR90107A\/ORG31540) with pure anti-factor Xa activity: a phase II evaluation","volume":"102","author":"The Rembrandt Investigators","year":"2000","journal-title":"Circulation"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.401S_bib42","first-page":"127","article-title":"Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism","volume":"82","author":"Schellong","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib43","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0037-1612901","article-title":"Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism","volume":"85","author":"Aschwanden","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1067\/mva.2000.110352","article-title":"Compression and walking versus bed rest in the treatment of proximal deep venous thrombosis with low molecular weight heparin","volume":"32","author":"Partsch","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1024\/0301-1526.30.3.195","article-title":"Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation","volume":"30","author":"Partsch","year":"2001","journal-title":"Vasa"},{"key":"10.1378\/chest.126.3_suppl.401S_bib46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0140-6736(85)90459-3","article-title":"Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis","volume":"2","author":"Lagerstedt","year":"1985","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib47","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM197910183011602","article-title":"Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis","volume":"301","author":"Hull","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib48","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0741-5214(91)90184-V","article-title":"Lower extremity calf thrombosis: to treat or not to treat?","volume":"14","author":"Lohr","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib49","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0140-6736(92)93285-U","article-title":"Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism","volume":"340","author":"Research Committee of the British Thoracic Society","year":"1992","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib50","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism: Duration of Anticoagulation Trial Study Group","volume":"332","author":"Schulman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib51","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1055\/s-0038-1649783","article-title":"Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis","volume":"74","author":"Levine","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis","volume":"306","author":"Hull","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib53","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib54","first-page":"148a","article-title":"A randomized trial evaluating long-term low-molecular-weight heparin therapy for three months versus intravenous heparin followed by warfarin sodium [abstract]","volume":"100","author":"Hull","year":"2002","journal-title":"Blood"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.401S_bib55","article-title":"Safety and efficacy results for a study investigating the long-term out-of-hospital treatment of patients with proximal-vein thrombosis using subcutaneous low-molecular-weight heparin versus warfarin [abstract]","author":"Hull","year":"2001","journal-title":"Thromb Haemost"},{"issue":"suppl","key":"10.1378\/chest.126.3_suppl.401S_bib56","first-page":"P137a","article-title":"A randomised trial evaluating long-term low-molecular-weight heparin therapy for three months vs. intravenous heparin followed by warfarin sodium in patients with current cancer [abstract]","author":"Hull","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib58","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199702063360601","article-title":"The duration of oral anticoagulant therapy after a second episode of venous thromboembolism: The Duration of Anticoagulation Trial Study Group","volume":"336","author":"Schulman","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib59","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis","volume":"345","author":"Agnelli","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib61","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib62","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib63","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/archinte.1997.00440400077009","article-title":"Recurrence of venous thromboembolism in patients with familial thrombophilia","volume":"157","author":"van Den Belt","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib64","doi-asserted-by":"crossref","first-page":"128","DOI":"10.7326\/0003-4819-138-2-200301210-00014","article-title":"Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system","volume":"138","author":"Crowther","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib65","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJM199702063360602","article-title":"The risk of recurrent venous thromboembolism in patients with an Arg506\u2013> Gln mutation in the gene for factor V (factor V Leiden)","volume":"336","author":"Simioni","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib66","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib67","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9343(98)00060-6","article-title":"Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy: Duration of Anticoagulation Study Group","volume":"104","author":"Schulman","year":"1998","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid-antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib69","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib70","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.290.8.1071","article-title":"D-dimer levels and risk of recurrent venous thromboembolism","volume":"290","author":"Eichinger","year":"2003","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM199909093411104","article-title":"The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation","volume":"341","author":"De Stefano","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib72","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198212303072704","article-title":"Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis","volume":"307","author":"Hull","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib73","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1056\/NEJMoa035241","article-title":"A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome","volume":"349","author":"Crowther","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib74","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa030104","article-title":"Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran","volume":"349","author":"Schulman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib75","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0268-960X(02)00008-5","article-title":"The post-thrombotic syndrome: current knowledge, controversies, and directions for future research","volume":"16","author":"Kahn","year":"2002","journal-title":"Blood Rev"},{"key":"10.1378\/chest.126.3_suppl.401S_bib76","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archinte.162.10.1144","article-title":"Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis","volume":"162","author":"Kahn","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(96)12215-7","article-title":"Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis","volume":"349","author":"Brandjes","year":"1997","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1378\/chest.126.3_suppl.401S_bib78","first-page":"72","article-title":"Below-knee compression stockings for prevention of the post-thrombotic syndrome: a randomized study [abstract]","volume":"32","author":"Prandoni","year":"2002","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1378\/chest.126.3_suppl.401S_bib79","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/archinte.161.17.2105","article-title":"Prevention and treatment of postphlebitic syndrome: results of a 3-part study","volume":"161","author":"Ginsberg","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib80","first-page":"1303","article-title":"Intermittent compression units for severe post-phlebitic syndrome: a randomized crossover study","volume":"160","author":"Ginsberg","year":"1999","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib81","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-0038-1651011","article-title":"A double blind three center clinical trial on the short-term efficacy of 0-(beta-hydroxyethyl)-rutosides in patients with post-thrombotic syndrome","volume":"62","author":"de Jongste","year":"1989","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib82","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archderm.134.11.1356","article-title":"Horse-chestnut seed extract for chronic venous insufficiency: a criteria-based systematic review","volume":"134","author":"Pittler","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib83","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0011-393X(96)80115-9","article-title":"Preliminary comparison of the clinical efficacy and tolerability of low-molecular-weight dermatan sulfate and calcium heparin in postthrombotic syndrome","volume":"57","author":"Catania","year":"1996","journal-title":"Curr Ther Res"},{"key":"10.1378\/chest.126.3_suppl.401S_bib84","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1177\/000331979604701009","article-title":"Postphlebitic syndrome: clinical activity and tolerability of desmin, new LMW dermatan sulfate","volume":"47","author":"Andreozzi","year":"1996","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.401S_bib85","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/026835559400900111","article-title":"A prospective study of the long-term efficacy of two different venoactive drugs in patients with post-thrombotic syndrome","volume":"9","author":"Monreal","year":"1994","journal-title":"Phlebology"},{"issue":"3 Suppl","key":"10.1378\/chest.126.3_suppl.401S_bib86","first-page":"33","article-title":"Antithrombotic treatment during acute inflammatory complications of patients affected by postphlebitic syndrome: LMW-heparin versus standard heparin","volume":"7","author":"Verardi","year":"1988","journal-title":"Int Angiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib87","first-page":"2443","article-title":"Treatment of postthrombotic syndrome with a mixture of enzymes [in German]","volume":"36","author":"Morl","year":"1986","journal-title":"Therapiewoche"},{"key":"10.1378\/chest.126.3_suppl.401S_bib88","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jama.279.6.458","article-title":"Risk of fatal pulmonary embolism in patients with treated venous thromboembolism","volume":"279","author":"Douketis","year":"1998","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib89","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archinte.160.2.229","article-title":"Low-molecular-weight heparin vs heparin in the treatment of patients with pulmonary embolism: American-Canadian Thrombosis Study Group","volume":"160","author":"Hull","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib90","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199709043371002","article-title":"A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism","volume":"337","author":"Simonneau","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-123-1-199507010-00001","article-title":"Comparing subcutaneous danaparoid with intravenous unfractionated heparin for the treatment of venous thromboembolism: a randomized controlled trial","volume":"123","author":"de Valk","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib92","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1055\/s-0038-1649960","article-title":"Subcutaneous low-molecular-weight heparin fragmin versus intravenous unfractionated heparin in the treatment of acute non massive pulmonary embolism: an open randomized pilot study","volume":"74","author":"Meyer","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib93","first-page":"1317","article-title":"Thrombolytic therapy for the treatment of acute pulmonary embolism","volume":"146","author":"Anderson","year":"1992","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib94","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1001\/jama.1970.03180120035007","article-title":"Urokinase pulmonary embolism trial: phase 1 results; a cooperative study","volume":"214","year":"1970","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib95","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/jama.1974.03230500024021","article-title":"Urokinase-streptokinase embolism trial: phase 2 results; a cooperative study","volume":"229","year":"1974","journal-title":"JAMA"},{"key":"10.1378\/chest.126.3_suppl.401S_bib96","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-90-5-802","article-title":"The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring","volume":"90","author":"Marder","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib97","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(88)92354-9","article-title":"Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism","volume":"2","author":"Goldhaber","year":"1988","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib98","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0140-6736(93)90274-K","article-title":"Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion","volume":"341","author":"Goldhaber","year":"1993","journal-title":"Lancet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib99","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1378\/chest.106.3.718","article-title":"Reduced dose bolus alteplase vs conventional alteplase infusion for pulmonary embolism thrombolysis: an international multicenter randomized trial: The Bolus Alteplase Pulmonary Embolism Group","volume":"106","author":"Goldhaber","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib100","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1093\/oxfordjournals.eurheartj.a015410","article-title":"Streptokinase vs alteplase in massive pulmonary embolism: a randomized trial assessing right heart haemodynamics and pulmonary vascular obstruction","volume":"18","author":"Meneveau","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1055\/s-2007-1003488","article-title":"Controversies of different regimens of thrombolytic therapy in acute pulmonary embolism","volume":"13","author":"Cella","year":"1987","journal-title":"Semin Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib102","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1161\/01.CIR.77.2.353","article-title":"Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism","volume":"77","author":"Verstraete","year":"1988","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.401S_bib103","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1378\/chest.98.6.1473","article-title":"A randomized trial of a single bolus dosage regimen of recombinant tissue plasminogen activator in patients with acute pulmonary embolism","volume":"98","author":"Levine","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib104","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1056\/NEJM198010093031502","article-title":"Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism","volume":"303","author":"Sharma","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib105","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM199205073261902","article-title":"The clinical course of pulmonary embolism","volume":"326","author":"Carson","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib106","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0002-8703(99)70243-7","article-title":"Hemodynamic effects of double bolus reteplase versus alteplase infusion in massive pulmonary embolism","volume":"138","author":"Tebbe","year":"1999","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib107","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0039-6109(16)42734-9","article-title":"Transvenous vena caval filtration and pulmonary embolectomy","volume":"62","author":"Stewart","year":"1982","journal-title":"Surg Clin North Am"},{"key":"10.1378\/chest.126.3_suppl.401S_bib108","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bjs.1800711220","article-title":"Surgical approaches to thromboembolism","volume":"71","author":"Greenfield","year":"1984","journal-title":"Br J Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib109","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.100.3.655","article-title":"Pulmonary embolectomy by catheter device in massive pulmonary embolism","volume":"100","author":"Timsit","year":"1991","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib110","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/01.CIR.96.8.2498","article-title":"A new treatment for severe pulmonary embolism: percutaneous rheolytic thrombectomy","volume":"96","author":"Koning","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3_suppl.401S_bib111","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1051-0443(97)70552-9","article-title":"Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism","volume":"8","author":"Fava","year":"1997","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib112","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0735-1097(00)00734-8","article-title":"Massive pulmonary embolism: percutaneous emergency treatment by pigtail rotation catheter","volume":"36","author":"Schmitz-Rode","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib113","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1378\/chest.114.5.1427","article-title":"Fragmentation of massive pulmonary embolism using a pigtail rotation catheter","volume":"114","author":"Schmitz-Rode","year":"1998","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib114","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0300-2896(01)75015-6","article-title":"Mechanical fragmentation and intrapulmonary fibrinolysis in the treatment of massive pulmonary embolism hemodynamic repercussions","volume":"37","author":"de Gregorio","year":"2001","journal-title":"Arch Bronconeumol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1378\/chest.105.3.888","article-title":"Rapid visualization of massive pulmonary emboli utilizing intravascular ultrasound","volume":"105","author":"Tapson","year":"1994","journal-title":"Chest"},{"key":"10.1378\/chest.126.3_suppl.401S_bib116","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0003-4975(91)90792-O","article-title":"Pulmonary embolectomy: a 20-year experience at one center","volume":"51","author":"Meyer","year":"1991","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib117","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/hrt.60.3.196","article-title":"Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases","volume":"60","author":"Gray","year":"1988","journal-title":"Br Heart J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib118","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0022-5223(19)35798-8","article-title":"Pulmonary embolectomy: a 25 year experience","volume":"92","author":"Clarke","year":"1986","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-2007-1013099","article-title":"The urgent pulmonary embolectomy: mechanical resuscitation in the operating theatre determines the outcome","volume":"47","author":"Ullmann","year":"1999","journal-title":"Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1051-0443(99)70185-5","article-title":"Recommended reporting standards for vena caval filter placement and patient follow-up: Vena Caval Filter Consensus Conference","volume":"10","author":"Greenfield","year":"1999","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib121","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0741-5214(93)90263-L","article-title":"Long-term experience with transvenous catheter pulmonary embolectomy","volume":"18","author":"Greenfield","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib122","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1067\/mva.2000.110346","article-title":"The percutaneous Greenfield filter: outcomes and practice patterns","volume":"32","author":"Greenfield","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib123","first-page":"253","article-title":"The Greenfield filter as the primary means of therapy in venous thromboembolic disease","volume":"172","author":"Fink","year":"1991","journal-title":"Surg Gynecol Obstet"},{"key":"10.1378\/chest.126.3_suppl.401S_bib124","first-page":"292","article-title":"Surgical prophylaxis for pulmonary embolism","volume":"60","author":"Leach","year":"1994","journal-title":"Am Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib125","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1148\/radiology.174.3.174-3-987","article-title":"Percutaneous inferior vena caval filters","volume":"174","author":"Dorfman","year":"1990","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.401S_bib126","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00000421-199404000-00005","article-title":"The Bird's Nest filter: an alternative to long-term oral anticoagulation in patients with advanced malignancies","volume":"17","author":"Hubbard","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib127","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1445-2197.1994.tb02154.x","article-title":"Early and late results after Bird's Nest filter placement in the inferior vena cava: clinical and duplex ultrasound follow up","volume":"64","author":"Lord","year":"1994","journal-title":"Aust N Z J Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1051-0443(91)72482-2","article-title":"LGM vena cava filter: objective evaluation of early results","volume":"2","author":"Murphy","year":"1991","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib129","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S1051-0443(94)71501-3","article-title":"LGM (Vena Tech) vena caval filter: experience at a single institution","volume":"5","author":"Millward","year":"1994","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1051-0443(92)72052-1","article-title":"Gunther vena caval filter: clinical appraisal","volume":"3","author":"Bull","year":"1992","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib131","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1177\/000313489906500906","article-title":"Bedside placement of inferior vena cava filters in the intensive care unit","volume":"65","author":"Tola","year":"1999","journal-title":"Am Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib132","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/s002709900305","article-title":"Indications, management, and complications of temporary inferior vena cava filters","volume":"21","author":"Linsenmaier","year":"1998","journal-title":"Cardiovasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib133","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/s100169900084","article-title":"The Tempofilter: a multicenter study of a new temporary caval filter implantable for up to six weeks","volume":"11","author":"Bovyn","year":"1997","journal-title":"Ann Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib134","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S1051-0443(98)70328-8","article-title":"Clinical experience with temporary vena caval filters","volume":"9","author":"Zwaan","year":"1998","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib135","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1051-0443(07)61590-5","article-title":"Gunther Tulip retrievable vena cava filter: results from the Registry of the Canadian Interventional Radiology Association","volume":"12","author":"Millward","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib136","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1148\/radiology.210.1.r99ja1353","article-title":"Acute upper extremity deep venous thrombosis: safety and effectiveness of superior vena caval filters","volume":"210","author":"Spence","year":"1999","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.401S_bib137","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0741-5214(98)70128-4","article-title":"Suprarenal filter placement","volume":"28","author":"Greenfield","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib138","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0741-5214(91)90074-5","article-title":"Results of a multicenter study of the modified hook-titanium Greenfield filter","volume":"14","author":"Greenfield","year":"1991","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib139","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0741-5214(89)90284-X","article-title":"Extended indications for placement of an inferior vena cava filter","volume":"10","author":"Rohrer","year":"1989","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib140","first-page":"111","article-title":"Interruption of the vena cava by means of the Greenfield filter: expanding the indications","volume":"103","author":"Golueke","year":"1988","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.401S_bib141","first-page":"12","article-title":"Greenfield filter as primary therapy for deep venous thrombosis and\/or pulmonary embolism in patients with cancer","volume":"109","author":"Cohen","year":"1991","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.401S_bib142","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF02016754","article-title":"Thromboembolic complications in patients with advanced cancer: anticoagulation versus Greenfield filter placement","volume":"5","author":"Calligaro","year":"1991","journal-title":"Ann Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib143","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0883-5403(11)80007-0","article-title":"Prophylactic and early therapeutic use of the Greenfield filter in hip and knee joint arthroplasty","volume":"6","author":"Emerson","year":"1991","journal-title":"J Arthroplasty"},{"key":"10.1378\/chest.126.3_suppl.401S_bib144","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/BF02600108","article-title":"Management and prevention of thromboembolic events in patients with cancer-related hypercoagulable states: a risky business","volume":"8","author":"Sarasin","year":"1993","journal-title":"J Gen Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00005373-199310000-00021","article-title":"Prophylactic vena cava filter insertion in severely injured trauma patients: indications and preliminary results","volume":"35","author":"Rogers","year":"1993","journal-title":"J Trauma"},{"key":"10.1378\/chest.126.3_suppl.401S_bib146","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/096721099400200112","article-title":"Use of the Greenfield filter in patients with major trauma","volume":"2","author":"Rosenthal","year":"1994","journal-title":"Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib147","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/00005131-199206000-00002","article-title":"Greenfield filter prophylaxis of pulmonary embolism in patients undergoing surgery for acetabular fracture","volume":"6","author":"Webb","year":"1992","journal-title":"J Orthop Trauma"},{"key":"10.1378\/chest.126.3_suppl.401S_bib148","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00005131-199206000-00001","article-title":"Vena caval filter use in orthopaedic trauma patients with recognized preoperative venous thromboembolic disease","volume":"6","author":"Collins","year":"1992","journal-title":"J Orthop Trauma"},{"key":"10.1378\/chest.126.3_suppl.401S_bib149","first-page":"461","article-title":"Venous interruption as prophylaxis of pulmonary embolism: vena cava filters","volume":"21","author":"Cotroneo","year":"1996","journal-title":"Rays"},{"key":"10.1378\/chest.126.3_suppl.401S_bib150","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1067\/mva.2000.110883","article-title":"Lessons learned from a 6-year clinical experience with superior vena cava Greenfield filters","volume":"32","author":"Ascher","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib151","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1051-0443(07)61907-1","article-title":"The 6-F nitinol TrapEase inferior vena cava filter: results of a prospective multicenter trial","volume":"12","author":"Rousseau","year":"2001","journal-title":"J Vasc Interv Radiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib152","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1148\/radiology.216.1.r00jl1254","article-title":"Inferior vena caval filters: review of a 26-year single-center clinical experience","volume":"216","author":"Athanasoulis","year":"2000","journal-title":"Radiology"},{"key":"10.1378\/chest.126.3_suppl.401S_bib153","first-page":"655","article-title":"Inferior vena cava filters: indications and results in 111 patients","volume":"126","author":"Mertens","year":"1998","journal-title":"Rev Med Chile"},{"key":"10.1378\/chest.126.3_suppl.401S_bib154","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa035451","article-title":"Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism","volume":"349","author":"The Matisse Investigators","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib155","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archinte.159.5.445","article-title":"Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study","volume":"159","author":"Heit","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib156","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"Agnelli","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib157","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0011-3840(00)80005-2","article-title":"Pulmonary endarterectomy","volume":"37","author":"Jamieson","year":"2000","journal-title":"Curr Probl Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib158","first-page":"261","article-title":"Our experience of surgical treatment for chronic pulmonary thromboembolism","volume":"7","author":"Masuda","year":"2001","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib159","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s003920050132","article-title":"Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension","volume":"86","author":"Mayer","year":"1997","journal-title":"Z Kardiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib160","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s002689900511","article-title":"Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy","volume":"22","author":"Gilbert","year":"1998","journal-title":"World J Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib161","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00005382-199807000-00003","article-title":"Reperfusion edema after thromboendarterectomy: radiographic patterns of disease","volume":"13","author":"Miller","year":"1998","journal-title":"J Thorac Imaging"},{"key":"10.1378\/chest.126.3_suppl.401S_bib162","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1010-7940(99)00116-5","article-title":"Angioscopic video-assisted pulmonary endarterectomy for post-embolic pulmonary hypertension","volume":"16","author":"Dartevelle","year":"1999","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib163","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1540-8191.1999.tb01014.x","article-title":"Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients","volume":"14","author":"Ando","year":"1999","journal-title":"J Card Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib164","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1213\/00000539-200002000-00006","article-title":"Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies","volume":"90","author":"Mares","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib165","first-page":"49","article-title":"Surgical treatment of chronic thromboembolic pulmonary hypertension","volume":"7","author":"Rubens","year":"2000","journal-title":"Can Respir J"},{"key":"10.1378\/chest.126.3_suppl.401S_bib166","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1010-7940(00)00584-4","article-title":"Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes","volume":"18","author":"D'Armini","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib167","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S1010-7940(01)00686-8","article-title":"Pulmonary thromboendarterectomy: risk factors for early survival and hemodynamic improvement","volume":"19","author":"Tscholl","year":"2001","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib168","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMra010902","article-title":"Chronic thromboembolic pulmonary hypertension","volume":"345","author":"Fedullo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib169","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-130-9-199905040-00014","article-title":"Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series","volume":"130","author":"McLaughlin","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib170","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0003-4975(99)01043-7","article-title":"Reoperative pulmonary thromboendarterectomy","volume":"68","author":"Mo","year":"1999","journal-title":"Ann Thorac Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib171","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0025-7753(00)71300-5","article-title":"Effect of topical and oral diclofenac on superficial thrombophlebitis caused by intravenous infusion","volume":"114","author":"Becherucci","year":"2000","journal-title":"Med Clin (Barc)"},{"key":"10.1378\/chest.126.3_suppl.401S_bib172","first-page":"92","article-title":"Treatment of superficial thrombophlebitis: a comparative trial between placebo, Hirudoid cream and piroxicam gel","volume":"79","author":"Bergqvist","year":"1990","journal-title":"Ann Chir Gynaecol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib173","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archinte.163.14.1657","article-title":"A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis","volume":"163","author":"Superficial Thrombophlebitis Treated by Enoxaparin Study Group","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib174","first-page":"160","article-title":"Therapeutic management of superficial venous thrombosis with calcium nadroparin: dosage testing and comparison with a non-steroidal anti-inflammatory agent","volume":"43","author":"Titon","year":"1994","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"10.1378\/chest.126.3_suppl.401S_bib175","first-page":"523","article-title":"High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg: a prospective, controlled, randomized study","volume":"87","author":"Marchiori","year":"2002","journal-title":"Haematologica"},{"key":"10.1378\/chest.126.3_suppl.401S_bib176","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/000331979905000701","article-title":"Superficial thrombophlebitis of the legs: a randomized, controlled, follow-up study","volume":"50","author":"Belcaro","year":"1999","journal-title":"Angiology"},{"key":"10.1378\/chest.126.3_suppl.401S_bib177","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/096721099300100106","article-title":"Upper-extremity deep venous thrombosis: analysis of 52 cases","volume":"1","author":"Burihan","year":"1993","journal-title":"Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib178","first-page":"1450","article-title":"Les thromboses veineuses du membre sup\u00e9rieur","volume":"65","author":"Goldstein","year":"1976","journal-title":"Schweiz Rundsch Med Prax"},{"key":"10.1378\/chest.126.3_suppl.401S_bib179","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1177\/096721090100900511","article-title":"Combined upper and lower extremity deep venous thrombosis","volume":"9","author":"Hingorani","year":"2001","journal-title":"Cardiovasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib180","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0950-821X(88)80069-0","article-title":"Deep vein thrombosis of the axillary-subclavian veins: epidemiologic data, effects of different types of treatment and late sequelae","volume":"2","author":"Lindblad","year":"1988","journal-title":"Eur J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib181","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1067\/mhl.2000.105758","article-title":"Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital","volume":"29","author":"Marinella","year":"2000","journal-title":"Heart Lung"},{"key":"10.1378\/chest.126.3_suppl.401S_bib182","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1055\/s-0037-1614319","article-title":"Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity","volume":"82","author":"Savage","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1378\/chest.126.3_suppl.401S_bib183","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0248-8663(98)80864-3","article-title":"Upper-extremity deep venous thrombosis: a report of 49 cases","volume":"19","author":"Marie","year":"1998","journal-title":"Rev Med Intern"},{"key":"10.1378\/chest.126.3_suppl.401S_bib184","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s100160010043","article-title":"Long-term results of venous revascularization for Paget-Schroetter syndrome in athletes","volume":"15","author":"Feugier","year":"2001","journal-title":"Ann Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0002-9343(99)00407-6","article-title":"Intraclot recombinant tissue plasminogen activator in the treatment of deep venous thrombosis of the lower and upper extremities","volume":"108","author":"Horne","year":"2000","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib186","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1067\/mva.2001.112708","article-title":"Outcome after thrombolysis and selective thoracic outlet decompression for primary axillary vein thrombosis","volume":"33","author":"Lokanathan","year":"2001","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib187","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0741-5214(93)90416-J","article-title":"Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein","volume":"17","author":"Machleder","year":"1993","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib188","first-page":"250","article-title":"Thromboses veineuses profondes des members sup\u00e9rieurs","volume":"25","author":"Massoure","year":"2000","journal-title":"J Mal Vasc"},{"key":"10.1378\/chest.126.3_suppl.401S_bib189","first-page":"187","article-title":"Thrombolyse in situ dans le traitement des thromboses veineuses d'effort du membre sup\u00e9rieur","volume":"22","author":"Pegis","year":"1997","journal-title":"J Mal Vasc"},{"key":"10.1378\/chest.126.3_suppl.401S_bib190","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF01616331","article-title":"Two different therapeutic modalities in the treatment of the upper extremity deep vein thrombosis: preliminary investigation with 20 case reports","volume":"9","author":"Petrakis","year":"2000","journal-title":"Int J Angiol"},{"key":"10.1378\/chest.126.3_suppl.401S_bib191","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/153857440003400105","article-title":"Long-term results of local thrombolysis followed by first rib resection: an encouraging clinical experience in treatment of subclavian vein thrombosis","volume":"34","author":"Yilmaz","year":"2000","journal-title":"Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib192","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0741-5214(98)70012-6","article-title":"Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: an effective treatment approach","volume":"27","author":"Lee","year":"1998","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib193","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/S0039-6060(05)80276-4","article-title":"Surgical management of subclavian vein obstruction, including six cases of subclavian vein bypass","volume":"118","author":"Sanders","year":"1995","journal-title":"Surgery"},{"key":"10.1378\/chest.126.3_suppl.401S_bib194","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0741-5214(96)80017-6","article-title":"Superior vena caval Greenfield filters: indications, techniques, and results","volume":"23","author":"Ascer","year":"1996","journal-title":"J Vasc Surg"},{"key":"10.1378\/chest.126.3_suppl.401S_bib195","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00063198-199907000-00008","article-title":"Upper extremity deep vein thrombosis","volume":"5","author":"Prandoni","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"10.1378\/chest.126.3_suppl.401S_bib196","first-page":"867","volume":"140","author":"Buller","year":"2004","journal-title":"Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215314987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215314987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T06:46:24Z","timestamp":1757918784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215314987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":196,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0012369215314987"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.401s","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithrombotic Therapy for Venous Thromboembolic Disease","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1378\/chest.126.3_suppl.401S","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}